Related references
Note: Only part of the references are listed.MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition
Michael W. M. Kuehn et al.
HAEMATOLOGICA (2015)
The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias
Anna K. Andersson et al.
NATURE GENETICS (2015)
MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition
Michael W. M. Kuehn et al.
HAEMATOLOGICA (2015)
EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations
Vincent-Philippe Lavallee et al.
BLOOD (2015)
Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia
N. Sandhoefer et al.
LEUKEMIA (2015)
Preclinical efficacy of MEK inhibition in Nras-mutant AML
Michael R. Burgess et al.
BLOOD (2014)
Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition
Julie Irving et al.
BLOOD (2014)
Synergistic antiproliferative and anticholesterogenic effects of linalool, 1,8-cineole, and simvastatin on human cell lines
Boris Rodenak Kladniew et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial
Nitin Jain et al.
CLINICAL CANCER RESEARCH (2014)
Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML
K. R. Kampen et al.
LEUKEMIA (2014)
PU.1 is essential for MLL leukemia partially via crosstalk with the MEIS/HOX pathway
J. Zhou et al.
LEUKEMIA (2014)
Identification of small molecules that support human leukemia stem cell activity ex vivo
Caroline Pabst et al.
NATURE METHODS (2014)
Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal
Iman Fares et al.
SCIENCE (2014)
Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias: A Study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group
Stefan Groeschel et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia
V. Grossmann et al.
LEUKEMIA (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A novel hierarchical prognostic model of AML solely based on molecular mutations
Vera Grossmann et al.
BLOOD (2012)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Scott R. Daigle et al.
CANCER CELL (2011)
MLL translocations, histone modifications and leukaemia stem-cell development
Andrei V. Krivtsov et al.
NATURE REVIEWS CANCER (2007)
Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias
C. G. Mullighan et al.
LEUKEMIA (2007)
Modeling the initiation and progression of human acute leukemia in mice
Frederic Barabe et al.
SCIENCE (2007)
The MLL partial tandem duplication in acute myeloid leukaemia
Jorg Basecke et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Prognostically useful gene-expression profiles in acute myeloid leukemia
PJM Valk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Gene expression profiling of pediatric acute myelogenous leukemia
ME Ross et al.
BLOOD (2004)
PU. 1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain
WD Cook et al.
BLOOD (2004)
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program
E Beillard et al.
LEUKEMIA (2003)
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program
J Gabert et al.
LEUKEMIA (2003)
A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes
TJ Ley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mutation analysis of the transcription factor PU.1 in younger adults (16 to 60 years) with acute myeloid leukemia:: a study of the AML Study Group Ulm (AMLSG ULM)
K Döhner et al.
BLOOD (2003)
Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia
C Steudel et al.
GENES CHROMOSOMES & CANCER (2003)
Function and regulation of Ena/VASP proteins
AV Kwiatkowski et al.
TRENDS IN CELL BIOLOGY (2003)
Are PU.1 mutations frequent genetic events in acute myeloid leukemia (AML)?
C Lamandin et al.
BLOOD (2002)
Heterozygous PU.1 mutations are associated with acute myeloid leukemia
BU Mueller et al.
BLOOD (2002)
C/EBP-β, C/EBP-δ, PU.1, AML1 genes:: mutational analysis in 381 samples of hematopoietic and solid malignancies
VA Vegesna et al.
LEUKEMIA RESEARCH (2002)
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
SA Armstrong et al.
NATURE GENETICS (2002)
Share Paper
